Percutaneous coronary intervention use of parenteral anticoagulants during PCI
|
Percutaneous Coronary Intervention Guidelines Microchapters |
|
PCI Approaches: |
|---|
|
CAD Revascularization: |
|
Pre-procedural Considerations: |
|
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
|
Quality and Performance Considerations: |
|
Percutaneous coronary intervention use of parenteral anticoagulants during PCI On the Web |
|
American Roentgen Ray Society Images of Percutaneous coronary intervention use of parenteral anticoagulants during PCI |
|
FDA on Percutaneous coronary intervention use of parenteral anticoagulants during PCI |
|
CDC on Percutaneous coronary intervention use of parenteral anticoagulants during PCI |
|
Percutaneous coronary intervention use of parenteral anticoagulants during PCI in the news |
|
Blogs on Percutaneous coronary intervention use of parenteral anticoagulants during PCI |
|
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]
Use of Parenteral Anticoagulants during PCI (DO NOT EDIT)[1]
| Class I |
| "1. An anticoagulant should be administered to patients undergoing PCI. (Level of Evidence: C)" |
References
- ↑ 1.0 1.1 Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter
|month=ignored (help)